Zhejiang Huakang Pharmaceutical Co., Ltd.

Shanghai Stock Exchange 605077.SS

Zhejiang Huakang Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2023: USD 364.85 M

Zhejiang Huakang Pharmaceutical Co., Ltd. Cash and Short-Term Investments is USD 364.85 M for the year ending December 31, 2023, a 141.94% change year over year. Cash and short-term investments are the sum of cash and short-term investments, representing the company's liquid assets.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2022 was USD 150.80 M, a -27.05% change year over year.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2021 was USD 206.73 M, a 442.39% change year over year.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2020 was USD 38.11 M, a 51.48% change year over year.
  • Zhejiang Huakang Pharmaceutical Co., Ltd. Cash and Short-Term Investments for the year ending December 31, 2019 was USD 25.16 M, a -6.11% change year over year.
Key data
Date Cash and Short-Term Investments Receivables Inventory Goodwill
Market news
Loading...
SV Wall Street
Shanghai Stock Exchange: 605077.SS

Zhejiang Huakang Pharmaceutical Co., Ltd.

Description

Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols worldwide. Its products include xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol being white crystal powder; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company is based in Kaihua County, China.

StockViz Staff

February 2, 2025

Any question? Send us an email